Cerity Partners LLC

Position in VCEL — Vericel Corp

CIK 1566475 NEW YORK, NY

Position in VCEL

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,830,986

-$277,507 QoQ

Shares Held

56,916

-2.8% QoQ

Ownership

0.111%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

10 quarters on record

Voting authority Sole 25.5973715651135.ToString("F0")% Shared 74.14259610654298.ToString("F0")% None 0.2600323283435238.ToString("F0")%

Healthcare · as of Mar 31, 2026

Cerity Partners LLC holds $355,132,750 across 115 Biotechnology names. VCEL ranks #18 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	296,654	$132,467,876
2	REGN	Regeneron Pharmaceuticals, Inc.	43,972	$33,974,525
3	CORT	Corcept Therapeutics Inc	731,689	$29,494,383
4	HALO	Halozyme Therapeutics, Inc.	349,137	$22,564,723
5	INCY	Incyte Corp	226,501	$21,318,272
6	BMRN	Biomarin Pharmaceutical Inc	263,389	$14,878,843
7	EXEL	Exelixis, Inc.	313,945	$13,465,100
8	JAZZ	Jazz Pharmaceuticals plc	45,746	$8,648,280

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,830,986	56,916	-2.8%	Shares	Sole	2026-05-15
2025-12-31	$2,108,493	58,553	+9.1%	Shares	Sole	2026-02-11
2025-09-30	$1,689,466	53,685	-10.4%	Shares	Sole	2025-10-22
2025-06-30	$2,549,596	59,920	-8.4%	Shares	Defined	2025-08-13
2025-03-31	$2,917,434	65,384	+10.1%	Shares	Sole	2025-04-30
2024-12-31	$3,261,434	59,396	-12.1%	Shares	Other	2025-02-13
2024-09-30	$2,855,593	67,588	+123.2%	Shares	Sole	2024-11-12
2024-06-30	$1,389,108	30,277	-11.7%	Shares	Sole	2024-08-13
2024-03-31	$1,783,973	34,294	+1239.6%	Shares	Defined	2024-05-14
2023-03-31	$75,059	2,560	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.